Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

They have been doing presentations for the past 3 to 4 years to generate partnership interest and have not been successful. Just a waste of shareholders time and money. They need to focus on their pipeline and actually post results.

No pre-clinical results from the eye trial, scar trial, samcyprone etc. Not even the ovarian cancer model therapy pre-clinical trial was PR'd. The only thing we got in December was that with the new cohorts of scar data the investigators identified RXI-109 as being better 60% of the time.

This management team stinks and why I sold off my shares. Get ready for the third reverse split coming up. don't kid yourselves into believing that they have time to bring the share price up. That's what I thought before the other reverse split they will reveal pictures or data that will boost the share price and that never happened.